Morphine for chronic breathlessness in COPD: improvement predictors-cross-sectional study.

Cornelia A VerberktMarieke H J van den Beuken-EverdingenJos M G A ScholsEmiel F M WoutersDaisy J A Janssen

Published in: BMJ supportive & palliative care (2022)

Worse baseline breathlessness and higher BMI are associated to a clinically meaningful improvement of breathlessness in patients using 20-30 mg oral sustained-release morphine. Opioid treatment should be considered in patients with COPD with severe breathlessness, taking into account the patient's BMI.

Keyphrases

chronic obstructive pulmonary disease
end stage renal disease
body mass index
lung function
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
weight gain
physical activity
cystic fibrosis
weight loss
patient reported